fda reversal on knockoff glp 1 Frontiers FDA Approves Wegovy Alternative for

If you continue to experience significant hunger after 46 weeks on a stable maintenance dose, discuss this with your healthcare provider, who may consider further dose escalation if appropriate and if you have not yet reached the maximum dose for your treatment goals

N., Sulicz, E

Weight loss is not a vanity metric

And how that came about is that you know, we got a note from Shilpa that said, This is what happened to me, and we invited her to come on the podcast

Arthritis: Doubles the risk of arthritis, especially in weight-bearing joints like the knees and hips

The question of whether these agents can be safely used together requires careful consideration of pharmacological properties, clinical evidence, and FDA guidance regarding thyroid-related safety concerns specific to GLP-1 receptor agonists